Showing results (81-90 of 481) with videos related to
Sort By:
Pageof 49
Circulation|April 13, 2005
Association of hemoglobin levels with clinical outcomes in acute coronary syndromesMarc S Sabatine, David A Morrow, Robert P Giugliano, et al.Journal of the American College of Cardiology|November 16, 2004
Acute changes in circulating natriuretic peptide levels in relation to myocardial ischemiaMarc S Sabatine, David A Morrow, James A de Lemos, et al.Journal of Clinical Lipidology|June 27, 2022
Time-averaged low-density lipoprotein cholesterol lowering with evolocumab: Pooled analysis of phase 2 trialsBelinda Schludi, Robert P Giugliano, Marc S Sabatine, et al.Journal of the American College of Cardiology|June 6, 2006
Intensive statin therapy and the risk of hospitalization for heart failure after an acute coronary syndrome in the PROVE IT-TIMI 22 studyBenjamin M Scirica, David A Morrow, Christopher P Cannon, et al.Journal of the American College of Cardiology|March 20, 2010
B-type natriuretic peptide and the effect of ranolazine in patients with non-ST-segment elevation acute coronary syndromes: observations from the MERLIN-TIMI 36 (Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST Elevation Acute Coronary-Thrombolysis In Myocardial Infarction 36) trialDavid A Morrow, Benjamin M Scirica, Marc S Sabatine, et al.Lancet (London, England)|August 31, 2010
Genetic variants in ABCB1 and CYP2C19 and cardiovascular outcomes after treatment with clopidogrel and prasugrel in the TRITON-TIMI 38 trial: a pharmacogenetic analysisJessica L Mega, Sandra L Close, Stephen D Wiviott, et al.American Heart Journal|November 26, 2013
Balancing the risk of mortality and major bleeding in the treatment of NSTEMI patients - a report from the National Cardiovascular Data RegistryNihar R Desai, Eric D Peterson, Anita Y Chen, et al.Journal of Thrombosis and Thrombolysis|March 27, 2012
Diagnostic evaluation of the MRP-8/14 for the emergency assessment of chest painAmit N Vora, Marc P Bonaca, Christian T Ruff, et al.Circulation|December 20, 2011
Evaluation of multiple biomarkers of cardiovascular stress for risk prediction and guiding medical therapy in patients with stable coronary diseaseMarc S Sabatine, David A Morrow, James A de Lemos, et al.European Journal of Preventive Cardiology|July 23, 2021
LDL-cholesterol lowering with evolocumab, and outcomes according to age and sex in patients in the FOURIER TrialPeter Sever, Ioanna Gouni-Berthold, Anthony Keech, et al.Pageof 49